Towards Healthcare
Robotics in Drug Discovery Market Top Key Players Shaping the Future

Robotics in Drug Discovery Market Emerging Trends by 2034

The robotics in drug discovery market is growing due to rising demand for faster, accurate research and reduced human error. Automation accelerated high-throughput screening and improved efficacy in early-stage drug development.

Content

  • Insight Code: 5794
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

The robotics in drug discovery market is set to grow rapidly from 2024 to 2034, fueled by advancements in automation, AI, and the need for efficient, accurate drug development solutions.

North America is currently leading the healthcare cybersecurity market due to its early adoption of automation, strong presence of key industry players, and a highly developed life sciences sector.

The robotics in drug discovery market includes 5 segments by component type, by type, by robot type, by end user, and by region.

Some key players include FANUC, ABB Ltd, Intuitive Surgical, KUKA, Smith& Nephew, Stryker, Yaskawa Electric

Key trends include the growth due to rising demand for faster, accurate research and reduced human error.

Common types include traditional industrial robots, collaborative robots (cobots), and autonomous robots. Each type is suited to different tasks, from precision pipetting to complex screening workflows.

Key components include hardware (robotic arms, sensors, and platforms), software (for workflow control and data analysis), and integration tools for connecting with laboratory information systems (LIMS).

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.
Any Questions